BB&T Securities’s Lifecore Biomedical LFCR Stock Holding History

BB&T Securities’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-26,000	Closed	-$307K	–	1210
2015 Q4	$307K	Buy	+26,000	New	+$319K	0.01%	914

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BB&T Securities's LFCR Position: Q1 2016 in Review

BB&T Securities sold out of Lifecore Biomedical (LFCR) in Q1 2016, closing a stake of 26,000 shares — an estimated $307K sold.

BB&T Securities first reported a position in LFCR in Q4 2015 and held it in 1 quarter. The position peaked at $307K in Q4 2015. 96 funds tracked by Wall St. Rank hold LFCR as of Q1 2016.

BB&T Securities reported no remaining Lifecore Biomedical position as of Q1 2016 after selling out during the quarter.
BB&T Securities sold 26,000 Lifecore Biomedical shares in Q1 2016, an estimated $307K.
BB&T Securities first reported a position in Lifecore Biomedical in Q4 2015 and held it in 1 quarter.
BB&T Securities's Lifecore Biomedical position peaked at $307K in Q4 2015.
96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2016.

Based on BB&T Securities's 13F filing for Q1 2016, filed 12 May 2016.